Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis
about
HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care?What will it take to eliminate pediatric HIV? Reaching WHO target rates of mother-to-child HIV transmission in Zimbabwe: a model-based analysisEstimating kidney function in HIV-infected adults in Kenya: comparison to a direct measure of glomerular filtration rate by iohexol clearanceThe Impact of Company-Level ART Provision to a Mining Workforce in South Africa: A Cost-Benefit AnalysisExpanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050Operations research in global health: a scoping review with a focus on the themes of health equity and impactThe macroeconomic consequences of renouncing to universal access to antiretroviral treatment for HIV in Africa: a micro-simulation model.Development, calibration and performance of an HIV transmission model incorporating natural history and behavioral patterns: application in South Africa.Modeling the cost-effectiveness of HIV treatment: how to buy the most 'health' when resources are limited.The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions.HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making.Life expectancies of South African adults starting antiretroviral treatment: collaborative analysis of cohort studies.Do support groups members disclose less to their partners? The dynamics of HIV disclosure in four African countries.Cost-effectiveness of genotype testing for primary resistance in BrazilThe cost-effectiveness of monitoring strategies for antiretroviral therapy of HIV infected patients in resource-limited settings: software toolCost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models.Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults.Current practices in laboratory monitoring of HIV infection.The cost-effectiveness of pre-exposure prophylaxis for HIV infection in South African women.The High Cost of HIV-Positive Inpatient Care at an Urban Hospital in Johannesburg, South AfricaCombination nucleoside/nucleotide reverse transcriptase inhibitors for treatment of HIV infection.Implications of adopting new WHO guidelines for antiretroviral therapy initiation in EthiopiaN348I in HIV-1 reverse transcriptase counteracts the synergy between zidovudine and nevirapine.Switch from 200 to 350 CD4 baseline count: what it means to HIV care and treatment programs in Kenya.Virological failure rates and HIV-1 drug resistance patterns in patients on first-line antiretroviral treatment in semirural and rural Gabon.The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis.Cost-effectiveness of antiretroviral therapy for preventionCost-effectiveness of World Health Organization 2010 guidelines for prevention of mother-to-child HIV transmission in ZimbabweHIV/AIDS related commodities supply chain management in public health facilities of Addis Ababa, Ethiopia: a cross-sectional survey.Challenges in evaluating the cost-effectiveness of new diagnostic tests for HIV-associated tuberculosis.Balancing efficiency, equity and feasibility of HIV treatment in South Africa - development of programmatic guidance.Implementation and Operational Research: Cost-Effectiveness of Antiretroviral Therapy and Isoniazid Prophylaxis to Reduce Tuberculosis and Death in People Living With HIV in Botswana.Could early antiretroviral therapy entail more risks than benefits in sub-Saharan African HIV-infected adults? A model-based analysis.Cost-effectiveness of HIV treatment as prevention in serodiscordant couples.Costing analysis of national HIV treatment and care program in Vietnam.Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis.Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.In silico study supports the efficacy of a reduced dose regimen for stavudine.Virological response and HIV drug resistance 12 months after antiretroviral therapy initiation at 2 clinics in Nigeria.
P2860
Q27010874-C8E06A3A-E780-4174-BAAB-4332C5031F62Q28478769-51B2249F-CB5C-41A0-AA75-F80EEFA24DF9Q28535213-CF323CAF-4948-4D58-A92A-2FC13B0917DFQ28608172-6F2B270F-7DD5-4807-B109-493683C442A8Q28732123-51AB2AD5-D54B-4529-86A5-0E9ACE7CD0D2Q29994616-9D8135C8-C406-4CBB-9B53-9C06F51F7BD1Q30415562-9035127A-C736-405D-BA44-A1CE69C32307Q33670446-740FD2D0-3A88-4B64-8138-8C28930252B7Q33854542-F2C37D12-0192-497C-9F8C-45AC5A388D3CQ34195493-36CD1AA4-CCF6-415C-AA5A-848C847D3292Q34339471-9C2351DA-D644-49C4-A9A8-7B8081061410Q34339523-078BEABD-1D63-4268-B507-3A07D68C01F9Q34667707-E9A33CC0-0ABD-4AD0-833E-1023D739BF68Q34774993-4CE18709-91E3-4EF8-9B9B-D28196D5E98DQ34964120-E72CD215-3BBC-418C-8349-4EDD5E67A72FQ35202699-63F08A17-65C4-48CE-B320-70746F1F7A54Q35504333-E599E48B-F213-46D0-B40D-85404DAB8CE1Q35610449-5464F468-65C5-4805-B833-4A5070287A16Q35770853-B9F7715E-11CC-4185-9B9D-21EB9D909F93Q35906897-B72EA31B-C7B0-45D8-B4EF-21AEF3CAFC5AQ35925982-D52A1330-B4D2-4E47-A1E7-2C0A07E60BCFQ36097686-6F6D67D9-72AF-4FC4-AFE8-BFCE593A1753Q36234401-EFAA5CBD-42B8-479E-96AC-BA3A37F76F7BQ36279266-DC1674CF-3D47-4D4A-A47E-D6FDEE8ECC38Q36325644-A2919FA9-536C-40B0-9083-AD6605FD6643Q36435445-32BC0CA1-5CC2-4819-A4DF-D775497A3C1DQ36454787-DA2B7BE2-9F2B-4E7C-9C87-E9BADE2093E4Q36486226-EB8BA302-5753-4768-A8EE-9BAD55647A54Q36517778-EEE6D77E-C022-4211-B957-1D8BF9B56674Q36758623-727C7300-30FE-481C-97B3-2FD5B4642C20Q37151512-DE7BD9E0-3596-40C8-8C07-45714438D121Q37365039-8D964B68-32BF-4FC7-AF2F-F618E42D7A15Q37461125-79A544A9-7089-45AD-BBD2-B8AC83BC4A13Q37483442-939F0523-9877-40C2-A2E7-E67E436C2B82Q37554064-67F81E57-9EE2-4E8D-8A2A-88DA6A4E4CD1Q37702374-BB1EB3F4-2D30-4C02-AD3D-D1BF7E0C2876Q39601881-CC1FD7AA-AB8B-49EB-B152-F35E02162637Q40032126-044BC43B-826C-46D4-8C3A-D78525D2E8B6Q41819035-281F65C1-CA21-4A4D-83F1-44EAD769151EQ44354582-C5230CD4-4089-4C89-BDDF-3B0B1136F22C
P2860
Scaling up the 2010 World Health Organization HIV Treatment Guidelines in resource-limited settings: a model-based analysis
description
2010 nî lūn-bûn
@nan
2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Scaling up the 2010 World Heal ...... ttings: a model-based analysis
@ast
Scaling up the 2010 World Heal ...... ttings: a model-based analysis
@en
Scaling up the 2010 World Heal ...... ttings: a model-based analysis
@nl
type
label
Scaling up the 2010 World Heal ...... ttings: a model-based analysis
@ast
Scaling up the 2010 World Heal ...... ttings: a model-based analysis
@en
Scaling up the 2010 World Heal ...... ttings: a model-based analysis
@nl
prefLabel
Scaling up the 2010 World Heal ...... ttings: a model-based analysis
@ast
Scaling up the 2010 World Heal ...... ttings: a model-based analysis
@en
Scaling up the 2010 World Heal ...... ttings: a model-based analysis
@nl
P2093
P2860
P50
P3181
P1433
P1476
Scaling up the 2010 World Heal ...... ttings: a model-based analysis
@en
P2093
A David Paltiel
Adam W Stoler
Andrea L Ciaranello
Sarah B Lorenzana
P2860
P304
P3181
P356
10.1371/JOURNAL.PMED.1000382
P407
P577
2010-12-21T00:00:00Z